Single User License: $2750
Member Price: FREE
Use code SUMMER at checkout for 50% OFF
Already a member? Login to access this report free.
Report Highlights
U.S. sales of environmental biotechnology products was valued at $241.2 million in 2012. This is expected to increase at a total compound annual growth rate (CAGR) of 7.9%, with 2013 sales of $261.9 million, rising to $382.3 million in 2018.
Report Includes
- An overview of the market for environmental biotechnology products and their utilization in a variety of waste treatment markets.
- Analyses of global market trends, with data from 2010 through 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Descriptions of various types of environmental biotechnology products, including microbial blends, nutrients, enzymes, and microbes.
- Examination of the environmental biotechnology industry on a worldwide basis from an application perspective.
- Detailed information on manufacturers; academic, and commercial developments; and innovative end-use biofuel products.
- Comprehensive company profiles of major product manufacturers.
Report Scope
This study contains comprehensive data concerning the products and applications involved in the use of microorganisms, enzymes and nutrients for waste treatment. This study will give insightful information from the perspective of the manufacturer and customer. Major product manufacturers are profiled and application markets are extensively reviewed. Detailed forecasts and analysis provide comprehensive market information on product sales, application markets and customers, potential end-use biofuel production and international opportunities.
Applications for wastewater treatment and bioremediation processes along with other treatment markets will be studied with information about current and future needs. A review of historical and current significance of government regulations, patents, and research and development will show how the market dynamics of environmental management affect future product sales. Also, the growing international markets for microorganism, enzyme and nutrient products will be listed. Information concerning U.S. exports and leading international companies will be analyzed.
Analyst Credentials
JON EVANS has been involved in business development and research for the biotechnology industry since 1984. He has been involved in sales, market research and strategy analysis with Fortune 500 clients - with a particular focus on business development challenges and strategies to optimize market performance. He holds a B.S. degree in biology from Rutgers University and MBA in business analysis from San Francisco State University.
Report Highlights
This Report:
- The U.S. market for environmental biotechnology products for waste treatment will increase from $166.8 million in 2007 to an estimated $180.3 million by the end of 2008. It should reach $261.3 million by 2013, a compound annual growth rate (CAGR) of 7.7%.
- Environmental biotechnology products have enormous potential in overseas markets.
- Rapid advances in biofuel technology will create a dynamic market where microbial products and the conversion of waste will become raw products and processes in producing biofuels.
Report Highlights
-
Total worldwide sales of environmental biotechnology products for U.S. manufacturers (microorganisms, enzymes, microbial blends, and nutrients) represent a total AAGR of 8.3% with current sales valued at $103.5 million and increasing to $153.87 million by year 2006.
-
Microbe blends are expected to reach the highest increase in sales with an AAGR of 9.4% with sales of $47.61 million and increasing to $74.55 million by 2006. Nutrients are second with expanded market growth of 8.8% AAGR and current sales estimated at $24.83 million and forecasted to grow to $37.83 million over the next 5 years.
-
Enzymes and microorganisms are predicted to keep a slower growth pace since these products represent more limited market potential. Enzymes should maintain an AAGR of 7.4% with current product sales of $20.71 million and reaching $29.56 million by 2006.
Related Reports
U.S. Medical Waste Treatment, Containment, Management and Disposal Markets
The U.S. medical waste treatment, containment management and disposal market was valued at $2 billion in 2007 and is expected to reach $2.5 billion in 2012. Total market value is expected to reach nearly $3.2 billion in 2017 after increasing at a compound annual growth rate (CAGR) of 4.8%.
Separation Systems for Commercial Biotechnology
The global market for commercial biotechnology separation systems reached $12.1 billion in 2010, $14.6 billion in 2011, and it will further grow to $26.7 billion at an estimated compound annual growth rate (CAGR) of 12.8% by 2016.
Water and Wastewater Treatment Technologies: Global Markets
The global market for wastewater treatment delivery equipment, instrumentation, process equipment, and treatment chemicals will increase at a 10.4% compound annual growth rate (CAGR) to exceed $93 billion in 2016, from a 2011 value of nearly $57 billion.
Recent Reports
Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets
The global market for single nucleotide polymorphism (SNP) is expected to grow from $32.0 billion in 2024 and is projected to reach $85.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% during the forecast period of 2024 to 2029.
In Vitro Diagnostics (IVD) Quality Controls: Global Market
The global market for in vitro diagnostics quality controls is expected to grow from $1.5 billion in 2024 and is projected to reach $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2024 to 2029.
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
RNAi Technologies and Global Markets
The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.
Metabolomics: Technologies and Global Markets
The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.
Top Trending Reports
Sensors: Technologies and Global Markets
The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.
Hydrogen Storage: Materials, Technologies and Global Markets
The global market for hydrogen storage materials and technologies is expected to grow from $5.3 billion in 2023 to $7.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.
Solid State Batteries: Global Markets
The global market for solid state batteries is estimated to increase from $274.0 million in 2023 to reach $1.7 billion by 2029, at a compound annual growth rate (CAGR) of 36.7% from 2024 through 2029.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More